Originally published In Press as doi:10.1074/jbc.M109141200 on November 8, 2001
J. Biol. Chem., Vol. 277, Issue 2, 1223-1228, January 11, 2002
Permissive Effect of Voltage on mGlu 7 Receptor Subtype Signaling
in Neurons*
Julie
Perroy,
Sylvain
Richard
,
Joel
Nargeot
,
Joel
Bockaert, and
Laurent
Fagni§
From the CNRS-UPR 9023 CCIPE and
CNRS-UPR 1142 IGH,
141 Rue de la Cardonille, 34094 Montpellier, Cedex 05, France
Received for publication, September 21, 2001, and in revised form, October 19, 2001
 |
ABSTRACT |
G protein-coupled receptors mobilize neuronal
signaling cascades which until now have not been shown to depend on the
state of membrane depolarization. Thus we have previously shown that the metabotropic glutamate receptor type 7 (mGlu7 receptor) blocks P/Q-type Ca2+ channels via activation of a
Go protein and PKC, in cerebellar granule cells. We show
here that the transient depolarizations used to evoke the studied
Ca2+ current were indeed permissive to activate this
pathway by a mGlu7 receptor agonist. Indeed, sustained depolarization
to 0 mV was sufficient to inhibit P/Q-type Ca2+ channels.
This effect involved a conformational change in voltage-gated sodium
channel independently of Na+ flux, activation of a
pertussis toxin-sensitive G-protein, inositol trisphosphate formation,
intracellular Ca2+ release, and PKC activity. Subliminal
sustained membrane depolarization became efficient in inducing inositol
trisphosphate formation, release of intracellular Ca2+ and
in blocking Ca2+ channels, when applied concomitantly with
the mGlu7a receptor agonist,
D,L-aminophosphonobutyrate. This
synergistic effect of membrane depolarization and mGlu7 receptor
activation provides a mechanism by which neuronal excitation could
control action of the mGlu7 receptor in neurons.
 |
INTRODUCTION |
The excitatory neurotransmitter, glutamate, mediates its effects
by activating ionotropic and metabotropic (mGlu) receptors. Eight genes
encoding mGlu receptors have been identified and classified into three
groups. The group I (mGlu1 and mGlu5 receptors) activates PLC through a
Gq protein, whereas group II (mGlu2 and mGlu3 receptors) and group III (mGlu4, mGlu6, mGlu7, and mGlu8 receptors) are coupled to
Gi/Go proteins (1). These receptors are widely
distributed throughout the mammalian brain (2-5), but only the mGlu7
receptor subtype is almost exclusively localized at presynaptic sites
(6-8).
Group II and III mGlu receptors, and particularly the mGlu7 receptor
subtype, inhibit synaptic transmission (1, 9). Thus in vitro
studies have shown that stimulation of mGlu7 receptors decreases
release of glutamate in cerebellar cultures (10) and GABA in striatal
cultures (11), promoting neuroprotection and excitotoxicity,
respectively. Moreover, we have recently shown that mGlu7 receptors
selectively block P/Q-type Ca2+ channels in neurons (12),
and these channels control transmitter release (13). Together these
studies suggest that mGlu7 receptors play an important role in the
modulation of synaptic transmission.
Recent studies have pointed out that in the rat locus coeruleus, group
III mGlu receptor agonists down-regulate high but not low frequency
synaptic activity (14), suggesting that this receptor action depends on
the state of neuronal depolarization. Moreover, a
voltage-dependent activation of a Go protein
has recently been shown in rat brain synaptoneurosomes (15). In light
of these results, and because the mGlu7 receptor is coupled to a
Go protein, this receptor is a potential candidate for
mobilization of both voltage- and Go
protein-dependent events in neurons. We therefore investigated, in cultured cerebellar granule cells, the effect of
membrane depolarization on this receptor signaling. We have previously
shown that the mGlu7 receptor-induced blockade of P/Q-type Ca2+ channels is independent of a direct action of
Go protein 
subunits on the Ca2+
channels, but results from
IP31 formation
and PKC activation (12). Here we show a synergistic effect of the
receptor activation and membrane depolarization.
 |
EXPERIMENTAL PROCEDURES |
Neuronal Culture Preparation and Transfection--
Primary
cultures of mouse cerebellar granule cells were prepared as previously
described (16). Since these cultured neurons do not express functional
native group III mGlu receptors in the soma (12), they were transfected
with an expression plasmid containing the mGlu7a receptor protein,
using a method described elsewhere (17). As only 10-20% neurons were
transfected using this method, the mGlu7a receptor was co-transfected
with the transfection marker, green fluorescent protein (GFP), for
single cell electrophysiological recording and intracellular
Ca2+ concentration ([Ca2+]i) measurement.
Electrophysiological Recordings--
Barium currents were
recorded using the whole cell configuration of the patch clamp
technique, at room temperature, from mGu7a/GFP-expressing cerebellar
granule cells, after 9 ± 1 days in vitro. The bathing medium contained (mM): BaCl2 (20), HEPES (10),
tetraethylammonium acetate (10), glucose (10), and Na acetate (120),
adjusted to pH 7.4 with Na-OH and 330 mOsm with Na acetate. Drug
solutions were prepared in this medium and pH of the solutions was
readjusted to 7.4 with NaOH. The NMDA receptor-channel blocker, MK-801
(1 µM), was added to all the solutions in order to avoid
activation of this receptor by the D-isoform of
D,L-AP4.2
We also added TTX (0.3 µM),
6-Cyano-7-nitroquinoxaline-2,3-dione (100 µM),
and 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt 250 µM), in order to block
Na+ flux through VGSCs and release of glutamate, as well as
activation of ionotropic glutamate receptors and endogenous mGlu1
receptors. Indeed, cultured cerebellar granule neurons do not express
functional native mGlu5 receptors (17-19). Patch pipettes had
resistances of 3-5 M
when filled with the following
internal solution (mM): Cs-acetate (100), CsCl (20),
MgCl2 (2), HEPES (10), glucose (15), EGTA (20 mM), Na2ATP (2 mM), and cAMP (1 mM), adjusted to pH 7.2 with CsOH and 300 mOsm with
Cs-acetate. In some experiments, intracellular EGTA was replaced by
BAPTA. Recordings started at least 5 min after breaking the membrane
patch and stabilization of evoked Ba2+ current (IBa).
Barium currents were evoked using voltage-clamp pulses of 500 ms
duration, from a holding potential of
80 mV to a test potential of 0 mV, at a rate of 0.1 Hz, except when specified in the text. Membrane
resistance was measured by applying hyperpolarizing pulses of 20 mV
amplitude and 55 ms duration, from a holding potential of
80 mV.
Current signals were recorded using an Axopatch 200 amplifier (Axon
Instruments, Foster City, CA), filtered at 1 kHz with an 8-pole Bessel
filter and sampled at 3 kHz on a Pentium II PC computer. Analyses were
performed using the pClamp6 program of Axon Instruments. Barium
currents were measured at their peak amplitude and expressed as
mean ± S.E. of the indicated number (n) of experiments.
Inositol Phosphate (IP) Synthesis Measurements--
The
procedure to measure IP accumulation in neurons was adapted from a one
previously described (20). Briefly, 1-week-old cerebellar cultures were
incubated for 14 h in culture medium containing 2 µCi/ml
myo-[3H]inositol (23.4 Ci/mol; Invitrogen,
Paris, France). Cells were then washed 3 times and incubated for 1 h at 37 °C in 1 ml of HEPES saline buffer (146 mM NaCl,
4.2 mM KCl, 0.5 mM MgCl2, 0.1% glucose, 20 mM HEPES, 0.3 µM TTX, 10 µM MK801, 100 µM
6,7-Dinitroquinoxaline-2,3-dione, and 250 µM
CPCCOEt, pH 7.4) supplemented with 1 unit/ml glutamate pyruvate
transaminase (Roche Molecular Biochemicals, Meylan, France) and 2 mM pyruvate (Sigma, St. Quentin-Fallavier, France). In
experiments where KCl was elevated to 30 or 100 mM, the
same respective amounts of NaCl were removed from the saline buffer
solution. This induced theoretical membrane steady-state
depolarizations to
40 and
10 mV, respectively, at 20 °C,
assuming an intracellular K+ concentration of 140 mM. Cells were then washed again with the same saline
buffer, and LiCl was added to a final concentration of 10 mM. The agonist was applied 15 min later and left for 5 min. The reaction was stopped by replacing the incubation medium with
0.5 ml of perchloric acid (5%) on ice. Supernatants were recovered and
IP purified on Dowex columns. Total radioactivity remaining in the
membrane fraction was counted after treatment with 10% Triton X-100,
0.1 N NaOH for 30 min and used as a standard. Results were
expressed as the ratio of [3H]IP production over
radioactivity present in the membranes. Experiments were performed in
triplicates for statistical analyses.
Similar results were obtained in mGlu7 receptor-transfected and
nontransfected cultures. Note that only data obtained from transfected
cultures are presented here. Given that only 10-20% neurons were
transfected with our method, this indicated that majority of
D,L-AP4-induced IP accumulation measured in
mGlu7 receptor-transfected cultures resulted from activation of the native mGlu7 receptors (12).
Measurement of Intracellular Ca2+--
Intracellular
Ca2+ level was measured in single cells, as previously
described (21). Briefly, the dual excitation ratiometric Ca2+-sensitive dye, Fura-2, was used for
[Ca2+]i imaging measurements by means of an
Olympus-LSR system (MERLIN; Life Science Resources Ltd., Cambridge,
UK). Cerebellar cultures were loaded by incubation with 2.5 µM Fura-2-acetoxymethyl ester and 0.02% pluronic acid
(F-127; Molecular Probes Inc., Eugene, OR) for 35 min at 37 °C in a
buffer medium containing (mM): NaCl (150), KCl (3),
MgCl2 (4), glucose (10), HEPES (10), TTX (3 × 10
4), MK801 (10
2),
6,7-Dinitroquinoxaline-2,3-dione (10
1), and
CPCCOEt (25 × 10
2), pH 7.4, adjusted with NaOH.
This medium was used to thoroughly rinse the cells before mounting them
on the stage of the inverted microscope of the Olympus-LSR system and
to prepare drug solutions. In experiments where 30 mM KCl
was added to the medium, NaCl concentration was lowered to 120 mM. The osmolarity of all the solutions was adjusted to 330 mOsm with NaCl. Epifluorescent illumination was via a SpectraMASTER
monochromator (Life Science Resources Ltd.) coupled to the microscope
fitted with a UV transparent oil objective (Uapo/340 40X/1.35). The
image was detected with an Astrocam 12/14 bit frame transfer digital
camera (Life Science Resources Ltd.). The Olympus-LSR system controlled
the illuminator and camera, and performed image ratioing and analysis.
The intensity of fluorescent light emission at
= 510 nm, using
excitation at 340 and 380 nm, was monitored for each single cell
analyzed. The ratio of fluorescence emission when excited at 340 nm
(the absorbance peak of Fura-2 bound to Ca2+) to 380 nm
(the absorbance peak of free Fura-2) was used as an index of
[Ca2+]i, with an increase in the fluorescence
ratio (F340/F380) signifying an increase in [Ca2+]i. Although
[Ca2+]i measurements were performed in cultured
cerebellar granule cells expressing the GFP reporter gene, one can
estimate that less than 1% of the signal at 340 nm excitation and less than 5% of the signal at 380 nm excitation were contributed by GFP.
Materials--
D,L-AP4,
6-Cyano-7-nitroquinoxaline-2,3-dione, and MK-801 were purchased
from Tocris Cockson (Bristol, UK), PTX, nimodipine, GF109203X, and
veratridine from RBI (Sigma), 
agatoxin-IVA from Alomone Labs
(Jerusalem, Israel), heparin from Calbiochem (Meudon, France), TTX from
Latoxan (Valence, France), Fura-2 from Molecular Probes (Eugene, OR),
and the GFP (pEGFP-N1) expression plasmid from
CLONTECH (Ozyme, Montigny-le-Bretonneux, France).
The R- and S-enantiomers of DPI 201-106 were
generous gifts from G. Romey (CNRS UPR 411, Nice, France).
 |
RESULTS |
Voltage-dependent Inhibition of Ca2+
Channels by mGlu7 Receptors--
Stimulation of mGlu7 receptors by
D,L-AP4 (500 µM) had no effect on
somatic whole cell IBa, in nontransfected cerebellar granule cells,
which was consistent with the presynaptic location of the receptor in
neurons (12). Therefore experiments were performed in cultured
cerebellar granule cells transfected with a mGlu7 receptor expression
plasmid. The receptor was expressed in both cell body and neurites
which allowed us to study its effect on somatic IBa. In mGlu7
receptor-transfected cerebellar granule cells application of the
receptor agonist, D,L-AP4 (500 µM), at a steady state potential of
80 mV, did not
affect IBa evoked at the end of the application (mean ± S.E. = 1 ± 1% inhibition; n = 6; Fig.
1, period 1). In contrast,
application of D,L-AP4, combined with transient
and repetitive depolarizations (which evoked IBa), induced a
progressive and potent inhibition (39 ± 2%; n = 6) of the current that last upon wash out of the agonist (Fig. 1,
period 2) (12). These results indicated that mGlu7 receptors
inhibited Ca2+ channels under conditions where cerebellar
granule cells were transiently and repetitively depolarized, but not in
resting neurons.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Voltage-dependent action of
D,L-AP4 on IBa. Barium currents were
evoked by 500-ms depolarization pulses applied at a frequency of 0.1 Hz. The graph represents the current amplitude relative to
the current average amplitude measured before period 1. During
period 1, membrane potential was held for 1 min at 80 mV,
in the absence of depolarization pulse. Traces are representative IBa
recorded at different times of the experiment indicated by the
arrows. Note that D,L-AP4 inhibited
IBa when applied concomitantly with (period 2), but in the
absence of (period 1) depolarization pulses. Similar results
were obtained in 5 other neurons.
|
|
Sustained Depolarization Inhibited P/Q-type
Ca2+Channels--
Because inhibition of
Ca2+ channels by mGlu7 receptors was dependent on transient
and repetitive depolarization, we examined the effect of membrane
depolarization per se (in the absence of receptor agonist) on the channel activity. To mimic physiological activity, we stimulated neurons using 20-ms depolarization pulses, from
80 to 0 mV. When applied at a frequency of 0.1 Hz, these stimulations
evoked IBa of stable amplitude over a period of at least 45 min (Fig.
2A, open circles).
Increasing the frequency of the depolarization pulses up to 25 Hz
decreased IBa amplitude (Fig. 2A, points). This
frequency-dependent decrease in amplitude of the current
was reversible immediately after cessation of the tetanic stimulation
if the train of depolarization pulses last for less than 30 s
(Fig. 2A, 1). On the other hand, a 1-min train of
transient depolarizations induced a long lasting inhibition of the
current (Fig. 2A, 2). To quantify this blockade
we replaced the high frequency train of stimulation by a single square
pulse depolarization of equivalent duration. Thus maintaining the cell for 1 min at a steady state potential of
80 mV did not alter IBa
evoked after this resting period (0 ± 1% inhibition,
n = 6, Fig. 2B, 1). On the other hand,
holding the cell for 1 min at 0 mV inhibited IBa evoked after cessation
of this steady state depolarization period (40 ± 2% inhibition;
n = 6; Fig. 2B, 2). This effect
was voltage- (Fig. 2C) and time-dependent (Fig.
2D). After the sustained depolarization period, neither
membrane resistance (not shown), nor IBa inactivation kinetics (Fig.
2E) were significantly altered, indicating that inhibition
of IBa did not result from change in passive properties of the membrane
or biophysical properties of the Ca2+ channels. We
interpreted the reversible decrease in IBa amplitude observed after a
short train of stimulations or sustained depolarization shorter than
10 s, as a classical Ca2+ channel inactivation. On the
other hand, we tentatively interpreted the long lasting decrease
induced by longer depolarization trains, or sustained steady state
depolarization, as a pure Ca2+ channel inhibition.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Depolarization-induced IBa inhibition.
A, amplitude of whole cell IBa evoked by 20-ms
depolarization pulses applied at a frequency of 0.1 Hz (open
circles) or 25 Hz (points). Note the decrease in
amplitude of the current evoked by high, but no low frequency
depolarization pulses. This decrease in amplitude was reversible after
short (1), but not long (2) high frequency
depolarization pulses. B, in this and the following figures,
IBa was evoked by 500-ms depolarization pulses applied at a frequency
of 0.1 Hz. The graph represents IBa amplitude measured as
described in the legend to Fig. 1. During periods 1,
2, and 3, membrane potential was held for 1 min
at 80 mV (1) or 0 mV (2 and 3), in
the absence of transient depolarization pulses. In A and
B, traces are representative of IBa recorded at different
times of the experiment (arrows). Similar results as those
in A and B were obtained in 5 other neurons.
C and D, voltage (C) and time
(D) dependence of the depolarization-induced inhibition of
IBa. Each value is the mean ± S.E. of at least five experiments.
E, represensative IBa traces recorded before (control) and
after a 1-min period of steady-state membrane potential at 80 and 0 mV. Original traces (on the left) were normalized (on the
right) for better comparison of their inactivation kinetics.
Note that although of smaller amplitude, IBa recorded after a
steady-state depolarization to 0 mV displayed similar inactivation
kinetics as control IBa.
|
|
The following data supported this hypothesis. First, IBa evoked after a
sustained depolarization to 0 mV (Fig. 2B, 2),
although of smaller amplitude, still displayed similar inactivation
kinetics (Fig. 2E). Second, IBa inhibition was mediated
through intracellular messengers. Thus, inhibition of IBa induced by
sustained depolarization was abolished by PTX, the PKC inhibitor
GF109203X, intracellular dialysis of the IP3 receptor
antagonist heparin, or intracellular Ca2+ chelator BAPTA
(Fig. 3A). Moreover,
KCl-induced depolarization increased basal IP accumulation, in a
PTX-dependent manner (Fig. 3B). Taken together
these results suggested that inhibition of Ca2+ channels
induced by sustained depolarization was distinct from their classical
voltage-dependent inactivation, since it involved a
Gi/Go protein, intracellular Ca2+,
and PKC.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 3.
Voltage-induced inhibition of IBa involved
intracellular second messengers. A, percentage of IBa
inhibition induced by 1 min steady-state depolarization to 0 mV,
obtained under the following conditions: after PTX treatment, after 30 min treatment with GF109203X (10 µM), in the presence of
intracellular BAPTA (20 mM) or heparin (400 µg/ml). Each
bar of the histogram is the mean ± S.E. of at least
five experiments. B, IP formation measured under the
indicated conditions. *, significantly different from basal;
p < 0.01.
|
|
We then searched for the voltage sensor of this inhibitory pathway.
Since voltage-induced inhibition of IBa was blocked by PTX (Fig.
3A), the voltage-sensitive step of this phenomenon should be
either upstream Gi/Go protein activation, or
the Gi/Go protein itself. Previous studies have
shown the existence of a Go protein activation through a
conformational change of VGSCs, regardless of the Na+
current (15). Since cerebellar granule cells express functional somatic
VGSCs (
145 pA/pF Na+ current) (17), we examined whether
these channels were involved in the depolarization-induced inhibition
of Ca2+ channels. Since experiments were performed in the
presence of TTX, the effects observed here were obviously independent
of Na+ flux through VGSCs. The
R-4-[3-(4-diphenylmethyl1-piperazinyl)-2-hydroxypropoxyl]-1H-indole-2-carbonitrile (R-DPI 201-106; 50 µM, 10 min), a drug that blocks VGSC
conformational changes (22), also blocked the voltage-induced
inhibition of IBa (2 ± 5% inhibition, n = 8, Fig. 4A). Interestingly, this
drug has been shown to block depolarization induced activation of
Go protein in synaptoneurosomes (15). The potent and
selective VGSC activator, veratridine, shifted the voltage-induced
inhibition of IBa toward more negative potentials (Fig. 6B,
filled triangles). The S-DPI 201-106 (50 µM,
10 min treatment), which mimics the action of veratridine on VGSC (22),
also mimicked the effect of veratridine on IBa inhibition (data not
shown). In the absence of sustained depolarization, neither veratridine
nor S- or R-DPI 201-106 significantly altered IBa (1 ± 2, 2 ± 4, and 2 ± 1% inhibition, respectively; n = 10 for both conditions). These results suggested that VGSCs were the
voltage sensors that triggered the depolarization-induced inhibition of
Ca2+ channels.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Membrane depolarization-mediated inhibition
of P/Q-type Ca2+ channels involved activation of
Na+ channels. Same as in the legend of Fig.
2B, but in a R-DPI treated neuron (A) or
untreated neurons (B and C). The square
pulses indicate 1 min steady-state depolarizations to 0 mV.
Aga, -agatoxin-IVA (250 nM). For each panel,
similar results were obtained in at least seven other
experiments.
|
|
We then explored which type of Ca2+ channel was inhibited
by the sustained depolarization. After application of
-agatoxin-IVA (250 nM), the toxin-resistant IBa was not significantly
affected by subsequent sustained depolarization (38 ± 2%
inhibition with
-agatoxin-IVA; 2 ± 0.4% inhibition with
depolarization, n = 7, Fig. 4B) and vice
versa (40 ± 1.8% inhibition with depolarization; 2. 5 ± 1.2% inhibition with subsequent
-agatoxin-IVA application, n = 8, Fig. 4C). The Ca2+
channels inhibited by sustained depolarization were therefore of the
P/Q-type.
Synergistic Action of mGlu7 Receptors and Membrane
Depolarization on Ca2+ Channel Inhibition--
Since
the mGlu7 receptor and membrane depolarization shared common
mechanisms, inhibition of IBa by these factors should be mutually
occluded. This hypothesis was confirmed by the following experiments.
We have seen here above (Fig. 1) that in mGlu7 receptor-transfected cerebellar granule cells, application of the receptor agonist, D,L-AP4 (500 µM), during
repetitive and transient depolarizations, progressively inhibited IBa
(39 ± 2% inhibition; n = 6). Interestingly, the
amount of IBa remaining after this action of
D,L-AP4 was not significantly affected by
subsequent sustained depolarization (36 ± 3% inhibition with
D,L-AP4; 3 ± 2% inhibition with
depolarization; n = 5; Fig.
5A). Conversely, after
sustained depolarization, D,L-AP4 application
(associated with repetitive transient depolarizations) did not further
inhibit the remaining IBa (39 ± 3% inhibition with
depolarization; 1 ± 1% inhibition with
D,L-AP4; n = 6; Fig. 5B). These results indicated a mutual occlusion of the
effects of sustained depolarization and mGlu7 receptor activation.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5.
Mutual occlusion of
D,L-AP4- and depolarization-induced inhibition
of Ca2+ channels. Amplitude of IBa was expressed as
described in the legend to Fig. 1. D,L-AP4 was
applied before (A) or after (B) a 1-min
steady-state depolarization to 0 mV (square pulse). Note the
nonadditive inhibitory effects of voltage and
D,L-AP4.
|
|
We then assessed whether or not voltage and mGlu7 receptor could act
synergistically to inhibit Ca2+ channels. Transient and
successive depolarization pulses applied at 0.1 Hz frequency (Fig. 1),
or a 1-min steady-state depolarization to
40 mV (Fig.
6, A, 1, and
B, filled circles), did not per se affect IBa. Similarly to these subliminal stimulations,
D,L-AP4 applied at a steady state potential of
80 mV did not alter IBa (Figs. 1 and 6, B, open
circles). However, a 1-min steady-state depolarization to
40 mV,
combined with a D,L-AP4 application inhibited
IBa by 20% (Fig. 6, A, 2, and
B, open circles). These results indicated a
synergistic inhibitory effect of mGlu7 receptors and membrane
depolarization on IBa. We verified that this synergistic effect
involved VGSCs. Application of the VGSC blocker, R-DPI 201-106,
antagonized the action of D,L-AP4 applied
concomitantly with transient depolarization pulses (7 ± 3%
inhibition; n = 5). Moreover, co-application, but not
separate applications, of veratridine and
D,L-AP4, at a membrane potential of
60 mV,
significantly inhibited IBa (Fig. 6B, filled and
open triangles). These results indicated that the mGlu7
receptor action depended on activation of VGSCs.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
Synergistic action of membrane depolarization
or veratridine and D,L-AP4. A,
IBa amplitude was expressed as described in the legend to Fig. 1. A
1-min steady-state depolarization to 40 mV was applied in the absence
or presence of D,L-AP4. Note that only
concomitant depolarization and D,L-AP4
application inhibited IBa. B, percentage inhibition of IBa
expressed as a function of membrane potential (1 min steady-state
depolarization), obtained under the indicated conditions. Each value is
the mean ± S.E. of at least five experiments. C,
inositol phosphate formation measured under the indicated conditions.
*, significantly different from basal (p < 0.01).
D, intracellular Ca2+ release induced by
D,L-AP4- and/or 30 mM KCl (average
of 15 individual neurons).
|
|
This synergistic effect of mGlu7 receptor and membrane depolarization
was also observed on the receptor intracellular signaling cascade.
Thus, basal IP level was not affected by 30 mM KCl
(equivalent to
40 mV depolarization), nor by
D,L-AP4 alone, but increased when KCl and
D,L-AP4 were co-applied (Fig. 6C).
The synergistic action of KCl and D,L-AP4 was
also evident on evoked intracellular Ca2+ release. Thus
D,L-AP4 or 30 mM KCl alone did not
induce any significant Ca2+ response, but together evoked
marked and reversible intracellular Ca2+ release (Fig.
6D). These results indicated that coincident subliminal membrane depolarization and mGlu7 receptor activation were required for
the synthesis of IP3 and intracellular Ca2+ release.
It is worth noting that a high concentration (100 mM) of
KCl (equivalent to a steady-state depolarization to
10 mV) induced a
similar IP response as a co-application of 100 mM KCl and
D,L-AP4 (Fig. 6C). This result was
consistent with the nonadditive inhibitory effects of a sustained
depolarization to 0 mV and D,L-AP4 application on IBa (Figs. 5 and 6, B, open and filled
circles).
 |
DISCUSSION |
The present study shows that a long duration train of high
frequency depolarization pulses, or a prolonged single steady state depolarization, can inhibit P/Q-type Ca2+ channels through
a VGSC-Go protein-PLC-dependent pathway. These results provides the first electrophysiological evidence for a voltage-dependent activation of a G-protein via VGSCs,
independently of Na+ flux. We also show that subliminal
depolarizations were permissive for activation of this signaling
cascade by the mGlu7 receptor (Fig.
7).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 7.
Model for P/Q-type Ca2+ channel
inhibition through synergistic activation of Go protein by
voltage and mGlu7 receptor. Coincident activation of VGSC
(1) and mGlu7 receptor (2) results in activation
of a Go protein and PLC (3). This in turn leads
to IP3 (4) and diacylglycerol (DAG)
formation (5), followed by IP3-induced Ca2+
release from intracellular stores (6). The released
Ca2+ and diacylglycerol then stimulates PKC, which in turn
blocks P/Q-type Ca2+ channels (7).
|
|
Inhibition of the P/Q-type Ca2+ channel induced by
sustained membrane depolarization was different from the classical
voltage-mediated inactivation of these channels, since P/Q-type
Ca2+ channel inactivation has been previously described to
be reversible, virtually abolished when Ba2+ was used as
charge carrier, and should not depend on G protein or PKC activation
(23, 24).
Our results were consistent with previous biochemical studies showing a
voltage-dependent interaction of VGSC with Go
protein in rat brain synaptoneurosomes (15). Indeed, R-DPI 201-106, a
drug that blocks depolarization-induced activation of Go
protein in this preparation (15), also blocked the
depolarization-induced inhibition of Ca2+ channels in
cerebellar granule cells. Although it is difficult to determine from
the present study whether or not Go protein activation
occurred during activation or inactivation of VGSCs, studies in
synaptoneurosomes suggested that this may happen as long as
depolarization lasts (15). We show here that
voltage-dependent activation of Go protein
through VGSCs resulted in IP3 formation and intracellular
Ca2+ release. Evidence for depolarization-induced
IP3 formation has been previously reported in skeletal
muscle (25), and hyperpolarization has been suggested to reduce
agonist-induced generation of IP3 in rabbit mesenteric
artery (26). Thus, the voltage-dependent activation of
Go protein and IP3 synthesis observed here may
not be specific for cerebellar granule cells.
We found a synergistic action of VGSCs and mGlu7 receptors on
IP3 formation and intracellular Ca2+ release.
Voltage-dependent IP3-mediated Ca2+
release has also been reported in coronary artery during stimulation of
metabotropic cholinergic receptors (27). Moreover, during stimulation
of metabotropic purinergic receptors, membrane depolarization can
stimulate the release of Ca2+ from
IP3-sensitive stores, in rat megakaryocytes. Consistent with our findings, the voltage sensor of this effect has been proposed
to be upstream the purinergic receptors (28).
Two alternative hypotheses can be proposed to explain the synergistic
action of voltage and mGlu7 receptor in neurons. The mGlu7 receptors
and VGSCs may share the same Go protein, or independently activate distinct Go proteins. Whatever the type of
coupling to Go protein, a synergistic action of the
receptor and VGSC was required to inhibit P/Q-type Ca2+
channels. This provided a mechanism by which neuronal activity could
promote glutamate-mediated metabotropic effects. It is likely that this
mechanism occur at the axon terminal, since mGluR7 (6-8), PKC activity
(29), IP3-sensitive Ca2+ stores, and P/Q-type
Ca2+ channels (13, 30-32) are present at presynaptic sites
and control neurotransmitter release (10, 11). Thus high but not low
frequency axonal discharges promotes coincident activation of
presynaptic mGlu7 receptors by the neurotransmitter glutamate and
action potential-induced activation of VGSCs, in the axon terminal.
This coincident events would allow their synergistic inhibitory action
on presynaptic P/Q-type Ca2+ channels and synaptic
transmission. This hypothesis is consistent with the inhibitory effect
of group III mGlu receptors on high but not low frequency synaptic
transmission, observed in the rat locus coeuleus (14). It would also
provide a mechanism by which mGlu7 receptor knockout mice develop
epileptic seizures (33).
 |
ACKNOWLEDGEMENTS |
We thank Dr. J. P. Pin and F. Ango for
helpful discussions during preparation of the manuscript and Anne
Cohen-Solal for technical assistance. We also thank Dr. J. Saugstad
(Atlanta, GA) for the generous gift of the mGlu7a receptor cDNA and
Dr. G. Romey (CNRS UPR411, Nice, France) for generous gift of the
R- and S-enantiomers of DPI 201-106.
 |
FOOTNOTES |
*
This work was supported by grants from CNRS, AFM,
FRM, Bayer (France), and the Conseil Régional
Languedoc-Roussillon/HMR.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed.
Published, JBC Papers in Press, November 8, 2001, DOI 10.1074/jbc.M109141200
2
L. Fagni and M. Lafon-Cazal, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
IP3, inositol trisphosphate;
GFP, green fluorescent
protein;
[Ca2+]i, intracellular
[Ca2+];
BAPTA, 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
TTX, tetrodotoxin;
PTX, pertussis toxin;
VGSC, voltage-gated
sodium channel.
 |
REFERENCES |
| 1.
|
Conn, P. J.,
and Pin, J. P.
(1997)
Annu. Rev. Pharmacol. Toxicol.
37,
205-237
|
| 2.
|
Kinzie, J. M.,
Saugstad, J. A.,
Westbrook, G. L.,
and Segerson, T. P.
(1995)
Neuroscience
69,
167-176
|
| 3.
|
Ohishi, H.,
Akazawa, C.,
Shigemoto, R.,
Nakanishi, S.,
and Mizuno, N.
(1995)
J. Comp. Neurol.
360,
555-570
|
| 4.
|
Bradley, S. R.,
Levey, A. I.,
Hersch, S. M.,
and Conn, P. J.
(1996)
J. Neurosci.
16,
2044-2056
|
| 5.
|
Kinoshita, A.,
Shigemoto, R.,
Ohishi, H.,
van der Putten, H.,
and Mizuno, N.
(1998)
J. Comp. Neurol.
393,
332-352
|
| 6.
|
Kinzie, J. M.,
Shinohara, M. M.,
van den Pol, A. N.,
Westbrook, G. L.,
and Segerson, T. P.
(1997)
J. Comp. Neurol.
385,
372-384
|
| 7.
|
Shigemoto, R.,
Kulik, A.,
Roberts, J. D.,
Ohishi, H.,
Nusser, Z.,
Kaneko, T.,
and Somogyi, P.
(1996)
Nature
381,
523-525
|
| 8.
|
Shigemoto, R.,
Kinoshita, A.,
Wada, E.,
Nomura, S.,
Ohishi, H.,
Takada, M.,
Flor, P. J.,
Neki, A.,
Abe, T.,
Nakanishi, S.,
and Mizuno, N.
(1997)
J. Neurosci.
17,
7503-7522
|
| 9.
|
O'Connor, V., El,
Far, O.,
Bofill-Cardona, E.,
Nanoff, C.,
Freissmuth, M.,
Karschin, A.,
Airas, J. M.,
Betz, H.,
and Boehm, S.
(1999)
Science
286,
1180-1184
|
| 10.
|
Lafon-Cazal, M.,
Fagni, L.,
Guiraud, M. J.,
Mary, S.,
Lerner-Natoli, M.,
Pin, J. P.,
Shigemoto, R.,
and Bockaert, J.
(1999)
Eur. J. Neurosci.
11,
663-672
|
| 11.
|
Lafon-Cazal, M.,
Viennois, G.,
Kuhn, R.,
Malitschek, B.,
Pin, J. P.,
Shigemoto, R.,
and Bockaert, J.
(1999)
Neuropharmacology
38,
1631-1640
|
| 12.
|
Perroy, J.,
Prézeau, L., De,
Waard, M.,
Shigemoto, R.,
Bockaert, J.,
and Fagni, L.
(2000)
J. Neurosci.
20,
7896-7904
|
| 13.
|
Dunlap, K.,
Luebke, J. I.,
and Turner, T. J.
(1995)
Trends Neurosci.
18,
89-98
|
| 14.
|
Dube, G. R.,
and Marshall, K. C.
(2000)
J. Neurophysiol.
83,
1141-1149
|
| 15.
|
Anis, Y.,
Nurnberg, B.,
Visochek, L.,
Reiss, N.,
Naor, Z.,
and Cohen-Armon, M.
(1999)
J. Biol. Chem.
274,
7431-7440
|
| 16.
|
Van Vliet, B. J.,
Sebben, M.,
Dumuis, A.,
Gabrion, J.,
Bockaert, J.,
and Pin, J. P.
(1989)
J. Neurochem.
52,
1229-1239
|
| 17.
|
Ango, F.,
Albani-Torregrossa, S.,
Joly, C.,
Robbe, D.,
Michel, J. M.,
Pin, J. P.,
Bockaert, J.,
and Fagni, L.
(1999)
Neuropharmacology
38,
793-803
|
| 18.
|
Ango, F.,
Pin, J. P., Tu, J. C.,
Xiao, B.,
Worley, P. F.,
Bockaert, J.,
and Fagni, L.
(2000)
J. Neurosci.
20,
8710-8716
|
| 19.
|
Prezeau, L.,
Carrette, J.,
Helpap, B.,
Curry, K.,
Pin, J. P.,
and Bockaert, J.
(1994)
Mol. Pharmacol.
45,
570-577
|
| 20.
|
Blahos, J.,
Mary, S.,
Perroy, J.,
de Colle, C.,
Brabet, I.,
Bockaert, J.,
and Pin, J. P.
(1998)
J. Biol. Chem.
273,
25765-25769
|
| 21.
|
Boccara, G.,
Choby, C.,
Frapier, J. M.,
Nargeaot, J.,
Dayanithi, G.,
and Richard, S.
(1999)
Circ. Res.
85,
606-613
|
| 22.
|
Romey, G.,
Quast, U.,
Pauron, D.,
Frelin, C.,
Renaud, J. F.,
and Lazdunski, M.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
896-900
|
| 23.
|
Lee, A.,
Wong, S. T.,
Gallagher, D., Li, B.,
Storm, D. R.,
Scheuer, T.,
and Catterall, W. A.
(1999)
Nature
399,
155-159
|
| 24.
|
Lee, A.,
Scheuer, T.,
and Catterall, W. A.
(2000)
J. Neurosci.
20,
6830-6838
|
| 25.
|
Vergara, J.,
Tsien, R. Y.,
and Delay, M.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
6352-6356
|
| 26.
|
Itoh, T.,
Seki, N.,
Suzuki, S.,
Ito, S.,
Kajikuri, J.,
and Kuriyama, H.
(1992)
J. Physiol.
451,
307-328
|
| 27.
|
Ganitkevich, V.,
and Isenberg, G.
(1993)
J. Physiol. (Lond.)
470,
35-44
|
| 28.
|
Mahaut-Smith, M. P.,
Hussain, J. F.,
and Mason, M. J.
(1999)
J. Physiol. (Lond.)
515,
385-390
|
| 29.
|
Rodriguez-Moreno, A.,
Sistiaga, A.,
Lerma, J.,
and Sanchez-Prieto, J.
(1998)
Neuron
21,
1477-1486
|
| 30.
|
Regehr, W. G.,
and Mintz, I. M.
(1994)
Neuron
12,
605-613
|
| 31.
|
Takahashi, T.,
and Momiyama, A.
(1993)
Nature
366,
156-158
|
| 32.
|
Turner, T. J.,
Adams, M. E.,
and Dunlap, K.
(1992)
Science
258,
310-313
|
| 33.
|
Masugi, M.,
Yokoi, M.,
Shigemoto, R.,
Muguruma, K.,
Watanabe, Y.,
Sansig, G.,
van der Putten, H.,
and Nakanishi, S.
(1999)
J. Neurosci.
19,
955-963
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Ohana, O. Barchad, I. Parnas, and H. Parnas
The Metabotropic Glutamate G-protein-coupled Receptors mGluR3 and mGluR1a Are Voltage-sensitive
J. Biol. Chem.,
August 25, 2006;
281(34):
24204 - 24215.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.